What is Point of Care Testing for the Hepatitis B Virus?

Hepatitis B virus (HBV) Point of Care Testing (POCT) is a sort of diagnostic testing that may be carried out at or close to the location of patient care without the need for complex laboratory apparatus or skilled people.

What is the size of the market Global Point of Care Testing for Hepatitis B Virus?

The Global Point of Care Testing for Hepatitis B Virus Market was estimated to be worth USD 548.3 Million in 2022 and is projected to reach a value of USD 907.43 Million by 2030, growing at a CAGR of 6.5% during the forecast period 2023-2030.

What are the drivers of the Global Point of Care Testing for the Hepatitis B Virus Market?

Rising demand for early diagnosis and the development of advanced diagnostic technologies are the factors driving the Global Point of Care Testing for the Hepatitis B Virus Market.